(2E)-2-[(2E)-2-[3-[(E)-2-[1-[6-[[4-[(2S)-2-[[(2S)-5-amino-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-6-[4-[4-[[8-(diethylamino)-10-phenylphenazin-10-ium-2-yl]diazenyl]-N-methylanilino]butanoylamino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-oxobutyl]amino]-6-oxohexyl]-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-2-(4-sulfophenoxy)cyclohex-2-en-1-ylidene]ethylidene]-3,3-dimethyl-1-(4-sulfobutyl)indole-5-sulfonic acid

C110H142N18O23S4+2 — CID 44816109

IUPAC(2E)-2-[(2E)-2-[3-[(E)-2-[1-[6-[[4-[(2S)-2-[[(2S)-5-amino-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-6-[4-[4-[[8-(diethylamino)-10-phenylphenazin-10-ium-2-yl]diazenyl]-N-methylanilino]butanoylamino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-oxobutyl]amino]-6-oxohexyl]-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-2-(4-sulfophenoxy)cyclohex-2-en-1-ylidene]ethylidene]-3,3-dimethyl-1-(4-sulfobutyl)indole-5-sulfonic acid
SMILESCCN(CC)c1ccc2nc3ccc(/N=N/c4ccc(N(C)CCCC(=O)NCCCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]5CCCN5C(=O)CCCNC(=O)CCCCC[N+]5=C(/C=C/C6=C(Oc7ccc(S(=O)(=O)O)cc7)/C(=C/C=C7/N(CCCCS(=O)(=O)O)c8ccc(S(=O)(=O)O)cc8C7(C)C)CCC6)C(C)(C)c6cc(S(=O)(=O)O)ccc65)C(N)=O)cc4)cc3[n+](-c3ccccc3)c2c1
InChIInChI=1S/C110H140N18O23S4/c1-11-124(12-2)79-43-51-87-95(67-79)128(78-29-15-13-16-30-78)94-66-76(40-50-86(94)117-87)122-121-75-38-41-77(42-39-75)123(10)60-26-34-100(131)113-58-19-18-31-88(104(112)134)119-105(135)72(5)116-107(137)90(65-71(3)4)118-101(132)70-115-106(136)89(52-57-98(111)129)120-108(138)93-32-25-63-127(93)102(133)35-24-59-114-99(130)33-17-14-20-61-125-91-53-48-82(154(145,146)147)68-84(91)109(6,7)96(125)55-36-73-27-23-28-74(103(73)151-80-44-46-81(47-45-80)153(142,143)144)37-56-97-110(8,9)85-69-83(155(148,149)150)49-54-92(85)126(97)62-21-22-64-152(139,140)141/h13,15-16,29-30,36-51,53-56,66-69,71-72,88-90,93H,11-12,14,17-28,31-35,52,57-65,70H2,1-10H3,(H13-2,111,112,113,114,115,116,118,119,120,129,130,131,132,134,135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150)/p+2/t72-,88-,89-,90-,93-/m0/s1
InChIKeyQIMIJPGCMGUJGI-JXCSBHJNSA-P
MW2212.72 g/mol
LogP11.91
Rot. Bonds55

About (2E)-2-[(2E)-2-[3-[(E)-2-[1-[6-[[4-[(2S)-2-[[(2S)-5-amino-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-6-[4-[4-[[8-(diethylamino)-10-phenylphenazin-10-ium-2-yl]diazenyl]-N-methylanilino]butanoylamino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-oxobutyl]amino]-6-oxohexyl]-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-2-(4-sulfophenoxy)cyclohex-2-en-1-ylidene]ethylidene]-3,3-dimethyl-1-(4-sulfobutyl)indole-5-sulfonic acid

(2E)-2-[(2E)-2-[3-[(E)-2-[1-[6-[[4-[(2S)-2-[[(2S)-5-amino-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-6-[4-[4-[[8-(diethylamino)-10-phenylphenazin-10-ium-2-yl]diazenyl]-N-methylanilino]butanoylamino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-oxobutyl]amino]-6-oxohexyl]-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-2-(4-sulfophenoxy)cyclohex-2-en-1-ylidene]ethylidene]-3,3-dimethyl-1-(4-sulfobutyl)indole-5-sulfonic acid (PubChem CID 44816109) has the molecular formula C110H142N18O23S4+2 and a molecular weight of 2212.72 g/mol. Its IUPAC name is (2E)-2-[(2E)-2-[3-[(E)-2-[1-[6-[[4-[(2S)-2-[[(2S)-5-amino-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-6-[4-[4-[[8-(diethylamino)-10-phenylphenazin-10-ium-2-yl]diazenyl]-N-methylanilino]butanoylamino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-oxobutyl]amino]-6-oxohexyl]-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-2-(4-sulfophenoxy)cyclohex-2-en-1-ylidene]ethylidene]-3,3-dimethyl-1-(4-sulfobutyl)indole-5-sulfonic acid.

Molecular Properties

Compound Name(2E)-2-[(2E)-2-[3-[(E)-2-[1-[6-[[4-[(2S)-2-[[(2S)-5-amino-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-6-[4-[4-[[8-(diethylamino)-10-phenylphenazin-10-ium-2-yl]diazenyl]-N-methylanilino]butanoylamino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-oxobutyl]amino]-6-oxohexyl]-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-2-(4-sulfophenoxy)cyclohex-2-en-1-ylidene]ethylidene]-3,3-dimethyl-1-(4-sulfobutyl)indole-5-sulfonic acid
PubChem CID44816109
Molecular FormulaC110H142N18O23S4+2
Molecular Weight2212.72 g/mol
Exact Mass2210.94
IUPAC Name(2E)-2-[(2E)-2-[3-[(E)-2-[1-[6-[[4-[(2S)-2-[[(2S)-5-amino-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-6-[4-[4-[[8-(diethylamino)-10-phenylphenazin-10-ium-2-yl]diazenyl]-N-methylanilino]butanoylamino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-oxobutyl]amino]-6-oxohexyl]-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-2-(4-sulfophenoxy)cyclohex-2-en-1-ylidene]ethylidene]-3,3-dimethyl-1-(4-sulfobutyl)indole-5-sulfonic acid
SMILESCCN(CC)c1ccc2nc3ccc(/N=N/c4ccc(N(C)CCCC(=O)NCCCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]5CCCN5C(=O)CCCNC(=O)CCCCC[N+]5=C(/C=C/C6=C(Oc7ccc(S(=O)(=O)O)cc7)/C(=C/C=C7/N(CCCCS(=O)(=O)O)c8ccc(S(=O)(=O)O)cc8C7(C)C)CCC6)C(C)(C)c6cc(S(=O)(=O)O)ccc65)C(N)=O)cc4)cc3[n+](-c3ccccc3)c2c1
InChIInChI=1S/C110H140N18O23S4/c1-11-124(12-2)79-43-51-87-95(67-79)128(78-29-15-13-16-30-78)94-66-76(40-50-86(94)117-87)122-121-75-38-41-77(42-39-75)123(10)60-26-34-100(131)113-58-19-18-31-88(104(112)134)119-105(135)72(5)116-107(137)90(65-71(3)4)118-101(132)70-115-106(136)89(52-57-98(111)129)120-108(138)93-32-25-63-127(93)102(133)35-24-59-114-99(130)33-17-14-20-61-125-91-53-48-82(154(145,146)147)68-84(91)109(6,7)96(125)55-36-73-27-23-28-74(103(73)151-80-44-46-81(47-45-80)153(142,143)144)37-56-97-110(8,9)85-69-83(155(148,149)150)49-54-92(85)126(97)62-21-22-64-152(139,140)141/h13,15-16,29-30,36-51,53-56,66-69,71-72,88-90,93H,11-12,14,17-28,31-35,52,57-65,70H2,1-10H3,(H13-2,111,112,113,114,115,116,118,119,120,129,130,131,132,134,135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150)/p+2/t72-,88-,89-,90-,93-/m0/s1
InChIKeyQIMIJPGCMGUJGI-JXCSBHJNSA-P
XLogP11.91
TPSA591.12 Ų
H-Bond Donors13
H-Bond Acceptors25
Rotatable Bonds55
Heavy Atoms155
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002212.72
LogP ≤ 511.91
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1025

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_A(478)', 'substructure': 'N/A'}, {'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}

Analyze (2E)-2-[(2E)-2-[3-[(E)-2-[1-[6-[[4-[(2S)-2-[[(2S)-5-amino-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-6-[4-[4-[[8-(diethylamino)-10-phenylphenazin-10-ium-2-yl]diazenyl]-N-methylanilino]butanoylamino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-oxobutyl]amino]-6-oxohexyl]-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-2-(4-sulfophenoxy)cyclohex-2-en-1-ylidene]ethylidene]-3,3-dimethyl-1-(4-sulfobutyl)indole-5-sulfonic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2E)-2-[(2E)-2-[3-[(E)-2-[1-[6-[[4-[(2S)-2-[[(2S)-5-amino-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-6-[4-[4-[[8-(diethylamino)-10-phenylphenazin-10-ium-2-yl]diazenyl]-N-methylanilino]butanoylamino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-oxobutyl]amino]-6-oxohexyl]-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-2-(4-sulfophenoxy)cyclohex-2-en-1-ylidene]ethylidene]-3,3-dimethyl-1-(4-sulfobutyl)indole-5-sulfonic acid?
The IUPAC name of (2E)-2-[(2E)-2-[3-[(E)-2-[1-[6-[[4-[(2S)-2-[[(2S)-5-amino-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-6-[4-[4-[[8-(diethylamino)-10-phenylphenazin-10-ium-2-yl]diazenyl]-N-methylanilino]butanoylamino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-oxobutyl]amino]-6-oxohexyl]-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-2-(4-sulfophenoxy)cyclohex-2-en-1-ylidene]ethylidene]-3,3-dimethyl-1-(4-sulfobutyl)indole-5-sulfonic acid (CID 44816109) is (2E)-2-[(2E)-2-[3-[(E)-2-[1-[6-[[4-[(2S)-2-[[(2S)-5-amino-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-6-[4-[4-[[8-(diethylamino)-10-phenylphenazin-10-ium-2-yl]diazenyl]-N-methylanilino]butanoylamino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-oxobutyl]amino]-6-oxohexyl]-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-2-(4-sulfophenoxy)cyclohex-2-en-1-ylidene]ethylidene]-3,3-dimethyl-1-(4-sulfobutyl)indole-5-sulfonic acid.
What is the SMILES notation for (2E)-2-[(2E)-2-[3-[(E)-2-[1-[6-[[4-[(2S)-2-[[(2S)-5-amino-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-6-[4-[4-[[8-(diethylamino)-10-phenylphenazin-10-ium-2-yl]diazenyl]-N-methylanilino]butanoylamino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-oxobutyl]amino]-6-oxohexyl]-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-2-(4-sulfophenoxy)cyclohex-2-en-1-ylidene]ethylidene]-3,3-dimethyl-1-(4-sulfobutyl)indole-5-sulfonic acid?
The canonical SMILES for (2E)-2-[(2E)-2-[3-[(E)-2-[1-[6-[[4-[(2S)-2-[[(2S)-5-amino-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-6-[4-[4-[[8-(diethylamino)-10-phenylphenazin-10-ium-2-yl]diazenyl]-N-methylanilino]butanoylamino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-oxobutyl]amino]-6-oxohexyl]-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-2-(4-sulfophenoxy)cyclohex-2-en-1-ylidene]ethylidene]-3,3-dimethyl-1-(4-sulfobutyl)indole-5-sulfonic acid is CCN(CC)c1ccc2nc3ccc(/N=N/c4ccc(N(C)CCCC(=O)NCCCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]5CCCN5C(=O)CCCNC(=O)CCCCC[N+]5=C(/C=C/C6=C(Oc7ccc(S(=O)(=O)O)cc7)/C(=C/C=C7/N(CCCCS(=O)(=O)O)c8ccc(S(=O)(=O)O)cc8C7(C)C)CCC6)C(C)(C)c6cc(S(=O)(=O)O)ccc65)C(N)=O)cc4)cc3[n+](-c3ccccc3)c2c1.
What is the InChIKey of (2E)-2-[(2E)-2-[3-[(E)-2-[1-[6-[[4-[(2S)-2-[[(2S)-5-amino-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-6-[4-[4-[[8-(diethylamino)-10-phenylphenazin-10-ium-2-yl]diazenyl]-N-methylanilino]butanoylamino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-oxobutyl]amino]-6-oxohexyl]-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-2-(4-sulfophenoxy)cyclohex-2-en-1-ylidene]ethylidene]-3,3-dimethyl-1-(4-sulfobutyl)indole-5-sulfonic acid?
The InChIKey is QIMIJPGCMGUJGI-JXCSBHJNSA-P. The full InChI is InChI=1S/C110H140N18O23S4/c1-11-124(12-2)79-43-51-87-95(67-79)128(78-29-15-13-16-30-78)94-66-76(40-50-86(94)117-87)122-121-75-38-41-77(42-39-75)123(10)60-26-34-100(131)113-58-19-18-31-88(104(112)134)119-105(135)72(5)116-107(137)90(65-71(3)4)118-101(132)70-115-106(136)89(52-57-98(111)129)120-108(138)93-32-25-63-127(93)102(133)35-24-59-114-99(130)33-17-14-20-61-125-91-53-48-82(154(145,146)147)68-84(91)109(6,7)96(125)55-36-73-27-23-28-74(103(73)151-80-44-46-81(47-45-80)153(142,143)144)37-56-97-110(8,9)85-69-83(155(148,149)150)49-54-92(85)126(97)62-21-22-64-152(139,140)141/h13,15-16,29-30,36-51,53-56,66-69,71-72,88-90,93H,11-12,14,17-28,31-35,52,57-65,70H2,1-10H3,(H13-2,111,112,113,114,115,116,118,119,120,129,130,131,132,134,135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150)/p+2/t72-,88-,89-,90-,93-/m0/s1.
What are the key properties of (2E)-2-[(2E)-2-[3-[(E)-2-[1-[6-[[4-[(2S)-2-[[(2S)-5-amino-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-6-[4-[4-[[8-(diethylamino)-10-phenylphenazin-10-ium-2-yl]diazenyl]-N-methylanilino]butanoylamino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-oxobutyl]amino]-6-oxohexyl]-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-2-(4-sulfophenoxy)cyclohex-2-en-1-ylidene]ethylidene]-3,3-dimethyl-1-(4-sulfobutyl)indole-5-sulfonic acid?
(2E)-2-[(2E)-2-[3-[(E)-2-[1-[6-[[4-[(2S)-2-[[(2S)-5-amino-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-6-[4-[4-[[8-(diethylamino)-10-phenylphenazin-10-ium-2-yl]diazenyl]-N-methylanilino]butanoylamino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-oxobutyl]amino]-6-oxohexyl]-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-2-(4-sulfophenoxy)cyclohex-2-en-1-ylidene]ethylidene]-3,3-dimethyl-1-(4-sulfobutyl)indole-5-sulfonic acid has a molecular weight of 2212.72 g/mol, XLogP of 11.91, 55 rotatable bonds, 13 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for (2E)-2-[(2E)-2-[3-[(E)-2-[1-[6-[[4-[(2S)-2-[[(2S)-5-amino-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-6-[4-[4-[[8-(diethylamino)-10-phenylphenazin-10-ium-2-yl]diazenyl]-N-methylanilino]butanoylamino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-oxobutyl]amino]-6-oxohexyl]-3,3-dimethyl-5-sulfoindol-1-ium-2-yl]ethenyl]-2-(4-sulfophenoxy)cyclohex-2-en-1-ylidene]ethylidene]-3,3-dimethyl-1-(4-sulfobutyl)indole-5-sulfonic acid is sourced from PubChem (CID 44816109), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).